| Quarterly Financials | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
Revenue  | 65 | 92 | 92 | 93 | 114 | 123 | 143 | 144 | 132 | 148 | 155 | 186 | 155 | 174 | 170 | 226 | 178 | 255 | 277 | 314 | 223 | 316 |
| Expenses | 52 | 69 | 70 | 70 | 91 | 95 | 111 | 118 | 108 | 119 | 122 | 146 | 120 | 179 | 140 | 182 | 147 | 198 | 206 | 224 | 156 | 211 |
| EBITDA | 14 | 23 | 22 | 23 | 23 | 28 | 31 | 26 | 24 | 29 | 34 | 41 | 35 | -5 | 30 | 44 | 31 | 57 | 70 | 91 | 67 | 105 |
| Operating Profit % | 20 % | 24 % | 24 % | 25 % | 20 % | 22 % | 21 % | 18 % | 18 % | 19 % | 20 % | 22 % | 22 % | -4 % | 16 % | 19 % | 17 % | 20 % | 25 % | 28 % | 25 % | 31 % |
| Depreciation | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 5 | 6 | 7 | 6 | 7 | 8 | 8 |
| Interest | 1 | 1 | 2 | 1 | 3 | 3 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 3 | 2 | 4 | 1 | 1 | 1 | 1 | 1 |
| Profit Before Tax | 11 | 0 | 19 | 21 | 18 | 23 | 29 | 22 | 20 | 26 | 30 | 37 | 31 | -10 | 24 | 37 | 20 | 50 | 63 | 83 | 58 | 96 |
| Tax | 3 | -15 | 5 | 5 | 4 | 5 | 9 | 1 | 6 | 7 | 7 | 10 | 9 | 7 | 6 | 12 | 5 | 13 | 18 | 20 | 14 | 24 |
| Net Profit | 9 | 15 | 15 | 15 | 14 | 18 | 20 | 21 | 15 | 19 | 22 | 27 | 22 | -17 | 18 | 26 | 15 | 38 | 46 | 63 | 44 | 72 |
| EPS in ₹ | 8.49 | 4.83 | 4.59 | 4.89 | 4.36 | 5.11 | 5.69 | 6.22 | 4.08 | 5.50 | 6.28 | 7.47 | 4.57 | -4.67 | 4.83 | 6.85 | 3.67 | 9.38 | 11.35 | 7.80 | 5.41 | 8.82 |
Ami Organics
Ami Organics
1,646.90
+93.50
(6.02%)
Q1 Quarterly Results are out. Check out the updated financials12 hours ago
Show All
Key Fundamentals
Market Cap
13,483.00 Cr
EPS
19.91
PE Ratio
60.18
Dividend Yield
0.09 %
Industry
Healthcare 52 Week High
1,582.70
52 Week Low
726.63
PB Ratio
10.29
Debt to Equity
0.12
Sector
Pharmaceuticals Analyst Rating and Forecast
- By Refinitiv from5 analysts
Actual
Company News
View All News
AcutaaS Chemicals MD Targets 25% Revenue Growth
23 hours ago
23 hours agoAcutaaS Chemicals' Managing Director expressed confidence in achieving approximately 25% revenue growth for the year.
Acutaas Chemicals (AMI Organics) delivered strong quarterly performance with revenue rising to 3.1 billion rupees from 2.44 billion rupees year-over-year. The company's EBITDA increased significantly to 966 million rupees compared to 481 million rupees in the same period last year, while EBITDA margin expanded to 31.65% from 19.76%. Net profit nearly doubled to 730 million rupees from 377 million rupees year-over-year, reflecting improved operational efficiency and business growth.
Acutaas Chemicals Limited Approves Q2 and Half-Year Financial Results1 day ago
Acutaas Chemicals Limited's Board of Directors approved the unaudited standalone and consolidated financial results for the second quarter and half year ended September 30, 2025. The results include Balance Sheet and Cash Flow Statement for the half year period. The financial results were reviewed by the Audit Committee and received a Limited Review Report from the company's statutory auditors, Maheshwari & Co., Chartered Accountants. The board meeting was held on October 17, 2025, commencing at 11:00 A.M.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,679.10 | #1 3,98,049.70 | 38.75 | #1 54,729.00 | 9.71 | #1 10,980 | -19.84 | 61.71 | |
6,621.50 | 1,75,222.50 | 76.19 | 9,712.00 | 18.67 | 2,191 | 26.74 | 72.60 | |
1,577.60 | 1,26,768.90 | 23.67 | 28,409.50 | 7.12 | 5,291 | 9.88 | 60.63 | |
3,584.30 | 1,19,599.80 | 60.49 | 11,539.40 | 6.99 | 1,911 | 19.91 | 53.74 | |
1,255.90 | 1,03,508.80 | #1 18.25 | 33,741.20 | 16.73 | 5,725 | 1.26 | 48.97 | |
2,476.60 | 1,01,344.60 | 53.48 | 12,744.20 | #1 20.90 | 2,007 | -18.14 | 47.04 | |
987.65 | 99,073.80 | 21.09 | 23,511.00 | 18.55 | 4,615 | 2.60 | 45.37 | |
1,940.00 | 89,121.90 | 23.79 | 22,909.50 | 13.74 | 3,306 | #1 51.64 | 46.82 | |
5,581.50 | 66,047.70 | 28.61 | 13,458.30 | 3.70 | 2,216 | 21.39 | 63.11 | |
1,101.00 | 64,254.10 | 19.04 | 32,345.60 | 9.43 | 3,484 | -10.24 | 50.87 |
Growth Rate
Revenue Growth
41.21 %
Net Income Growth
229.36 %
Cash Flow Change
-5.46 %
ROE
70.41 %
ROCE
52.45 %
EBITDA Margin (Avg.)
29.64 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 213 | 232 | 413 | 659 | 767 | 1,096 | 1,549 |
| Fixed Assets | 79 | 85 | 186 | 205 | 259 | 427 | 570 |
| Current Assets | 124 | 121 | 216 | 430 | 457 | 496 | 792 |
| Capital Work in Progress | 2 | 12 | 0 | 3 | 30 | 125 | 130 |
| Investments | 2 | 2 | 1 | 2 | 2 | 0 | 0 |
| Other Assets | 131 | 133 | 225 | 450 | 477 | 543 | 848 |
| Total Liabilities | 213 | 232 | 413 | 659 | 767 | 1,096 | 1,549 |
| Current Liabilities | 106 | 95 | 166 | 129 | 163 | 285 | 202 |
| Non Current Liabilities | 25 | 26 | 80 | 7 | 10 | 128 | 27 |
| Total Equity | 82 | 112 | 167 | 522 | 594 | 683 | 1,320 |
| Reserve & Surplus | 72 | 101 | 135 | 486 | 558 | 637 | 1,269 |
| Share Capital | 11 | 11 | 32 | 36 | 36 | 37 | 41 |
Cash Flow
| Cash Flow | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 0 | 3 | -2 | -0 | 3 | -1 | 8 | 20 | -1 | 156 |
| Investing Activities | -14 | -19 | -25 | -21 | -24 | -101 | -121 | -33 | -365 | -224 |
| Operating Activities | 10 | 29 | 9 | 15 | 27 | 28 | -12 | 66 | 125 | 118 |
| Financing Activities | 4 | -7 | 15 | 6 | 0 | 72 | 140 | -12 | 239 | 261 |
Share Holding
| % Holding | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | May 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
| Promoter | 49.71 % | 41.05 % | 41.05 % | 41.05 % | 41.05 % | 39.41 % | 39.41 % | 39.41 % | 39.41 % | 38.93 % | 39.91 % | 39.91 % | 39.07 % | 35.98 % | 35.97 % | 35.96 % | 35.96 % | 32.66 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 7.16 % | 0.00 % | 8.97 % | 10.01 % | 12.92 % | 13.87 % | 15.52 % | 16.48 % | 16.94 % |
| DIIs | 0.00 % | 4.85 % | 2.63 % | 4.44 % | 3.01 % | 3.28 % | 3.72 % | 3.63 % | 5.23 % | 5.94 % | 5.55 % | 6.81 % | 8.81 % | 14.81 % | 19.93 % | 20.24 % | 18.31 % | 22.38 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.01 % | 0.01 % | 0.01 % |
| Public / Retail | 0.00 % | 42.98 % | 46.69 % | 44.74 % | 44.74 % | 38.35 % | 38.64 % | 38.96 % | 37.44 % | 36.13 % | 27.13 % | 30.01 % | 28.79 % | 26.06 % | 24.72 % | 23.56 % | 24.19 % | 23.27 % |
| Others | 50.29 % | 11.11 % | 9.62 % | 9.77 % | 11.19 % | 18.96 % | 18.23 % | 18.00 % | 17.92 % | 11.84 % | 27.41 % | 14.30 % | 13.33 % | 10.22 % | 5.51 % | 4.71 % | 5.05 % | 4.74 % |
| No of Share Holders | 0 | 28 | 1,38,182 | 97,547 | 93,922 | 87,044 | 85,563 | 78,786 | 70,352 | 72,897 | 83,344 | 95,784 | 92,721 | 90,329 | 93,394 | 95,756 | 1,14,060 | 1,19,890 |
Dividend History
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3 | 3 | 3 | 1.5 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.67 | 0.55 | 0.25 | 0.09 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 01 Aug 2022 |  Dividend | ₹ 3.00 /share | 29 Jul 2022 | 469.45 | 519.43 |
| 18 Sept 2023 | Dividend | ₹ 3.00 /share | 18 Sept 2023 | 529.60 | 648.55 |
| 13 Sept 2024 | Dividend | ₹ 3.00 /share | 13 Sept 2024 | 596.08 | 730.05 |
| 20 Sept 2024 |  Annual General Meeting | NA | 20 Sept 2024 | 692.10 | 768.08 |
| 29 Oct 2024 |  Quarterly Result Announcement | NA | 29 Oct 2024 | 736.58 | 806.00 |
| 28 Jan 2025 | Quarterly Result Announcement | NA | 28 Jan 2025 | 988.83 | 953.60 |
| 16 Apr 2025 |  Change Of Name | NA | 16 Apr 2025 | 1,177.28 | 1,177.28 |
| 22 Feb 2025 |  Split | 5:10 | 25 Apr 2025 | 1,121.08 | 1,121.08 |
| 02 May 2025 | Quarterly Result Announcement | NA | 02 May 2025 | 1,100.75 | 1,130.50 |
| 10 May 2025 |  Extraordinary General Meeting | NA | 10 May 2025 | 1,177.28 | 1,160.05 |
| 30 Jul 2025 | Quarterly Result Announcement | NA | 30 Jul 2025 | 1,187.60 | 1,167.70 |
| 18 Sept 2025 | Dividend | ₹ 1.50 /share | 18 Sept 2025 | 1,130.50 | 1,472.35 |
| 25 Sept 2025 | Annual General Meeting | NA | 25 Sept 2025 | 1,413.30 | 1,449.70 |
| 17 Oct 2025 | Quarterly Result Announcement | NA | 17 Oct 2025 | 1,421.55 | 1,552.25 |
Announcements
Recording Of Earnings Conference Call Held On October 17 202517 hours ago
17 hours agoAnnouncement under Regulation 30 (LODR)-Press Release / Media Release23 hours ago
23 hours agoAnnouncement under Regulation 30 (LODR)-Investor Presentation23 hours ago
23 hours agoUnaudited Standalone And Consolidated Financial Results For Second Quarter And Half Year Ended September 30 20251 day ago
1 day agoBoard Meeting Outcome for Outcome Of Board Meeting Held On October 17 20251 day ago
1 day agoIntimation Of Earnings Conference Call Scheduled On Friday October 17 2025 At 3.30 P.M. (IST)7 days ago
7 days agoBoard Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025 To Be Held On October 17 20258 days ago
8 days agoCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 201810 days ago
10 days agoClosure of Trading WindowSep 26, 2025
Sep 26, 2025Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015Sep 25, 2025
Sep 25, 2025Announcement under Regulation 30 (LODR)-AllotmentSep 25, 2025
Sep 25, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 25, 2025
Sep 25, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 25, 2025
Sep 25, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 03, 2025
Sep 03, 2025Intimation Of Record Date For The Purpose Of Final Dividend For The FY 2024-25Sep 02, 2025
Sep 02, 2025Communication To Shareholders - Intimation On Deduction Of Tax On DividendSep 02, 2025
Sep 02, 2025Business Responsibility and Sustainability Reporting (BRSR)Sep 01, 2025
Sep 01, 2025Reg. 34 (1) Annual Report.Sep 01, 2025
Sep 01, 2025Reg. 34 (1) Annual Report.Sep 01, 2025
Sep 01, 2025Notice Of The 18Th AGM Of The Company Scheduled To Be Held On September 25 2025Sep 01, 2025
Sep 01, 2025Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015Aug 29, 2025
Aug 29, 2025Regulation 30 Update - Intimation Of Platinum Medal Accreditation/Rating By EcovadisAug 27, 2025
Aug 27, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 21, 2025
Aug 21, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 20, 2025
Aug 20, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 05, 2025
Aug 05, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 01, 2025
Aug 01, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 31, 2025
Jul 31, 2025Announcement Under Reg 30 Of SEBI (LODR) Regulations 2015Jul 30, 2025
Jul 30, 2025Recording Of Earnings Conference Call Held On July 30 2025Jul 30, 2025
Jul 30, 2025Statement Of Deviation & Variation For The Quarter Ended June 30 2025 - Preferential IssueJul 30, 2025
Jul 30, 2025Announcement under Regulation 30 (LODR)-Investor PresentationJul 30, 2025
Jul 30, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 30, 2025
Jul 30, 2025Unaudited Standalone And Consolidated Financial Results For First Quarter Ended June 30 2025Jul 30, 2025
Jul 30, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On July 30 2025Jul 30, 2025
Jul 30, 2025Intimation Of Change Of Name Of Wholly Owned Subsidiary Company From Ami Organics Electrolytes Private Limited To Acutaas Chemicals Electrolytes Private LimitedJul 28, 2025
Jul 28, 2025Intimation Of Earnings Conference Call Scheduled On Wednesday July 30 2025 At 4.30 P.M. (IST)Jul 25, 2025
Jul 25, 2025Board Meeting Intimation for Approval Of Unaudited Financial Results Of The Company For The Quarter Ended June 30 2025 To Be Held On July 30 2025Jul 24, 2025
Jul 24, 2025Announcement under Regulation 30 (LODR)-AcquisitionJul 23, 2025
Jul 23, 2025Intimation Of Name Change Of Wholly Owned Subsidiary CompanyJul 17, 2025
Jul 17, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 11, 2025
Jul 11, 2025Announcement under Regulation 30 (LODR)-Joint VentureJun 27, 2025
Jun 27, 2025Closure of Trading WindowJun 27, 2025
Jun 27, 2025Intimation Under Reg 30 Of SEBI (LODR) Regulations 2015Jun 10, 2025
Jun 10, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 04, 2025
Jun 04, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 23, 2025
May 23, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011May 21, 2025
May 21, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011May 20, 2025
May 20, 2025Announcement under Regulation 30 (LODR)-Change of Company NameMay 15, 2025
May 15, 2025Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMay 10, 2025
May 10, 2025Shareholder Meeting / Postal Ballot-Outcome of EGMMay 10, 2025
May 10, 2025Mutual Fund Holdings
Motilal Oswal Focused Fund Direct-Growth 
TRUSTMF Flexi Cap Fund Direct - Growth 
JM Small Cap Fund Direct - Growth 
Bank of India Manufacturing & Infrastructure Fund Direct-Growth 
Capitalmind Flexi Cap Fund Direct - Growth 
Helios Mid Cap Fund Direct-Growth 
Samco Multi Cap Fund Direct-Growth 
Groww Nifty Total Market Index Fund Direct - Growth 
Bandhan BSE Healthcare Index Fund Direct-Growth 
Angel One Nifty Total Market Index Fund Direct - Growth 
Mirae Asset Nifty Total Market Index Fund Direct-Growth 
Quant Healthcare Fund Direct - Growth 
Tata ELSS Fund Direct-Growth 
ICICI Prudential Children's Fund Direct-Growth 
ITI Small Cap Fund Direct-Growth Technical Indicators
RSI(14)
Neutral 78.80
ATR(14)
Volatile 53.18
STOCH(9,6)
Overbought 90.11
STOCH RSI(14)
Overbought 100.00
MACD(12,26)
Bullish 21.63
ADX(14)
Strong Trend 30.12
UO(9)
Bearish 69.56
ROC(12)
Uptrend And Accelerating 24.97
WillR(14)
Overbought -5.30
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
